Zymeworks

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zymeworks and other ETFs, options, and stocks.

About ZYME

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2).

CEO

Kenneth Harry Galbraith

CEOKenneth Harry Galbraith

Employees

277

Employees277

Headquarters

Middletown, Delaware

HeadquartersMiddletown, Delaware

Founded

2003

Founded2003

Employees

277

Employees277

ZYME Key Statistics

Market cap

1.03B

Market cap1.03B

Price-Earnings ratio

-9.73

Price-Earnings ratio-9.73

Dividend yield

—

Dividend yield—

Average volume

435.74K

Average volume435.74K

High today

$14.80

High today$14.80

Low today

$14.37

Low today$14.37

Open price

$14.52

Open price$14.52

Volume

22.14K

Volume22.14K

52 Week high

$17.70

52 Week high$17.70

52 Week low

$7.97

52 Week low$7.97

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell